Shao-dong Hong

State Key Laboratory Of Oncology In South China
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

EGFR activation disrupts immunotherapy response via SHP2-mediated suppression of tumor-intrinsic response to IFN-γ.

EGFR activation disrupts immunotherapy response via SHP2-mediated suppression of tumor-intrinsic response to IFN-γ.

Journal: The Journal of clinical investigation

Published: April 15, 2025

Role of antiangiogenic agents in first-line treatment for advanced NSCLC in the era of immunotherapy.

Role of antiangiogenic agents in first-line treatment for advanced NSCLC in the era of immunotherapy.

Journal: BMC cancer

Published: April 05, 2022

First-Line Treatment Options for PD-L1-Negative Non-Small Cell Lung Cancer: A Bayesian Network Meta-Analysis.

First-Line Treatment Options for PD-L1-Negative Non-Small Cell Lung Cancer: A Bayesian Network Meta-Analysis.

Journal: Frontiers in oncology

Published: January 23, 2021

Low Prognostic Nutritional Index Correlates with Worse Survival in Patients with Advanced NSCLC following EGFR-TKIs.

Low Prognostic Nutritional Index Correlates with Worse Survival in Patients with Advanced NSCLC following EGFR-TKIs.

Journal: PloS one

Published: September 15, 2015

The Efficacy of Combining EGFR Monoclonal Antibody With Chemotherapy for Patients With Advanced Nonsmall Cell Lung Cancer: A Meta-Analysis From 9 Randomized Controlled Trials.

The Efficacy of Combining EGFR Monoclonal Antibody With Chemotherapy for Patients With Advanced Nonsmall Cell Lung Cancer: A Meta-Analysis From 9 Randomized Controlled Trials.

Journal: Medicine

Published: August 28, 2015

Efficacy of Addition of Antiangiogenic Agents to Taxanes-Containing Chemotherapy in Advanced Nonsmall-Cell Lung Cancer: A Meta-Analysis and Systemic Review.

Efficacy of Addition of Antiangiogenic Agents to Taxanes-Containing Chemotherapy in Advanced Nonsmall-Cell Lung Cancer: A Meta-Analysis and Systemic Review.

Journal: Medicine

Published: August 08, 2015

Clinical analysis of 50 Eastern Asian patients with primary pulmonary large-cell neuroendocrine carcinoma.

Clinical analysis of 50 Eastern Asian patients with primary pulmonary large-cell neuroendocrine carcinoma.

Journal: OncoTargets and therapy

Published: June 11, 2015

Roles of immunohistochemical staining in diagnosing pulmonary squamous cell carcinoma.

Roles of immunohistochemical staining in diagnosing pulmonary squamous cell carcinoma.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: February 17, 2015

QoL analyses from INFORM study, a phase III study of gefitinib versus placebo as maintenance therapy in advanced NSCLC.

QoL analyses from INFORM study, a phase III study of gefitinib versus placebo as maintenance therapy in advanced NSCLC.

Journal: Scientific reports

Published: January 20, 2015

Multiple oncogenic mutations related to targeted therapy in nasopharyngeal carcinoma.

Multiple oncogenic mutations related to targeted therapy in nasopharyngeal carcinoma.

Journal: Chinese journal of cancer

Published: October 10, 2014

Showing 1-10 of 10

Last Updated: 09/26/2026